Skip to Main Content

3,432

Views

87

CrossRef citations to date

0

Altmetric

Research Article

Acridine Orange/exosomes increase the delivery and the effectiveness of Acridine Orange in human melanoma cells: A new prototype for theranostics of tumors

Elisabetta IessiAnti-Tumour Drugs Section, Department of Drug Research and Medicines Evaluation, National Institute of Health, Rome, Italy; View further author information

,

Mariantonia LogozziAnti-Tumour Drugs Section, Department of Drug Research and Medicines Evaluation, National Institute of Health, Rome, Italy; View further author information

,

Luana LuginiAnti-Tumour Drugs Section, Department of Drug Research and Medicines Evaluation, National Institute of Health, Rome, Italy; View further author information

,

Tommaso AzzaritoAnti-Tumour Drugs Section, Department of Drug Research and Medicines Evaluation, National Institute of Health, Rome, Italy; View further author information

,

Cristina FedericiAnti-Tumour Drugs Section, Department of Drug Research and Medicines Evaluation, National Institute of Health, Rome, Italy; View further author information

,

Enrico Pierluigi SpugniniSAFU Department, Regina Elena Cancer Institute, Rome, Italy; View further author information

,

Davide MizzoniAnti-Tumour Drugs Section, Department of Drug Research and Medicines Evaluation, National Institute of Health, Rome, Italy; View further author information

,

Rossella Di RaimoAnti-Tumour Drugs Section, Department of Drug Research and Medicines Evaluation, National Institute of Health, Rome, Italy; View further author information

,

Daniela F. AngeliniNeuroimmunology Unit, IRCCS Santa Lucia Foundation, Rome, Italy; View further author information

,

Luca BattistiniNeuroimmunology Unit, IRCCS Santa Lucia Foundation, Rome, Italy; View further author information

,

Serena CecchettiDepartment of Cell Biology and Neuroscience, National Institute of Health, Rome, ItalyView further author information

&

Stefano FaisAnti-Tumour Drugs Section, Department of Drug Research and Medicines Evaluation, National Institute of Health, Rome, Italy; Correspondence[email protected]
View further author information